Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Live Oak Bancshares CEO Sells 20,000 Shares in August 2026

James S. Mahan III, Chief Executive Officer and Director of Live Oak Bancshares, Inc. (NYSE:LOB), filed a Form 4 on August 21, 2026, disclosing the sale of 20,000 shares of Voting Common Stock across three transactions on August 19 and 20, 2026, all executed …

Aditi Sarkar | 21 August 2026

Circle Internet Group Director Sells 3,332 Shares

Director M. Michele Burns filed a Form 4 with the SEC on August 21, 2026, reporting the sale of 3,332 shares of Circle Internet Group, Inc. Class A Common Stock on August 20, 2026, under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 21 August 2026

Donnelley Financial Solutions CEO Sells 9,787 Shares

Daniel Leib, Chief Executive Officer and Director of Donnelley Financial Solutions, Inc., filed a Form 4 on August 21, 2026, disclosing the sale of 9,787 shares of common stock on August 19, 2026.

Vinay Lochav | 21 August 2026

Hyliion Holdings CTO Reports Share Disposition in Form 4

Joshua T. Mook, Chief Technology Officer of Hyliion Holdings Corp. (NYSE:HYLN), filed a Form 4 on August 21, 2026, disclosing the disposition of 10,700 shares of common stock at $3.33 per share on the same date.

Nitish Kishor | 21 August 2026

Hyliion Holdings CLO Disposes of Shares for Tax Withholding

Jose Miguel Oxholm, Chief Legal and Compliance Officer of Hyliion Holdings Corp., filed a Form 4 on August 21, 2026, reporting the disposition of 11,980 shares of common stock at $3.33 per share under an issuer-directed tax withholding arrangement.

Manish Choudhary | 21 August 2026

Hyliion Holdings CCO Reports Share Disposition in Form 4

Govindaraj Ramasamy, Chief Commercial Officer of Hyliion Holdings Corp. (NYSE:HYLN), filed a Form 4 on August 21, 2026, disclosing a disposition of common stock on that same date.

Vinay Lochav | 21 August 2026

SOPHiA GENETICS Chief Scientific Officer Sells Shares

Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), filed a Form 4 on August 21, 2026, reporting the sale of 20,000 ordinary shares across three transactions between August 19 and August 21, 2026.

Shwetambri Chauhan | 21 August 2026

Arcutis Biotherapeutics CMO Reports Share Sale for Tax Withholding

Patrick Burnett, Executive Vice President and Chief Medical Officer of Arcutis Biotherapeutics, Inc., filed a statement of changes in beneficial ownership on August 21, 2026, disclosing a sale of common stock on August 19, 2026, in connection with the vesting of Restricted Stock Units.

Vinay Lochav | 21 August 2026

SOPHiA GENETICS Chief People Officer Reports Share Sale

Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), filed a Form 4 on August 21, 2026, disclosing the exercise of share options and the subsequent sale of ordinary shares on August 19, 2026.

Manish Choudhary | 21 August 2026

Gen Digital Director Vlcek Sells 100,000 Common Shares

A Form 4 filed on August 21, 2026, with the SEC discloses that Ondrej Vlcek, a director of Gen Digital Inc. (NASDAQ:GEN), sold 100,000 shares of common stock on August 19, 2026.

Shwetambri Chauhan | 21 August 2026
Support

Hi! How can we help you today?

Loading…